Aveo Pharmaceuticals, Inc.
Clinical trials sponsored by Aveo Pharmaceuticals, Inc., explained in plain language.
-
New drug duo aims to extend life in tough-to-treat head and neck cancer
Disease control Recruiting nowThis phase 3 study tests whether adding ficlatuzumab to standard cetuximab helps people with recurrent or metastatic HPV-negative head and neck cancer live longer or keep their cancer from growing. About 410 adults will receive either the combination or a placebo plus cetuximab. …
Phase: PHASE3 • Sponsor: AVEO Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New drug aims to stop wasting in cancer patients
Symptom relief Recruiting nowThis early-stage study tests a drug called AV-380 in 30 adults with advanced cancer who are losing weight (cachexia). The drug targets a protein linked to weight loss. Researchers will check safety and how the drug works in the body when given with standard chemotherapy.
Phase: PHASE1 • Sponsor: AVEO Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated May 17, 2026 05:35 UTC